Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy

• Published in: Topics in catalysis Vol. 67; no. 1-4; pp. 203 - 217
• Main Authors: Rajendran, Sasireka, Ravi, Sai Nandhini, Nair, Vaishnavi M., Sree, R. Pooja, Packirisamy, Azhagu Saravana Babu, Palanivelu, Jeyanthi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.01.2024; Springer Nature B.V
• Subjects: Biomarkers; Cancer therapies; Catalysis; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; Diagnosis; Drug delivery systems; Industrial Chemistry/Chemical Engineering; Medical diagnosis; Nanoparticles; Nanotechnology; Original Paper; Pharmacy; Physical Chemistry; Side effects; Therapy; Tumors; Nano carriers; Biomarkers; Drug delivery; Nanomedicine; Cancer therapy; Cancer cells
• ISSN: 1022-5528; 1572-9028
• DOI: 10.1007/s11244-023-01893-6

The rapid advancement of nanotechnology in the production of nanomedicine agents holds enormous promise for improving cancer therapy techniques. Nanomedicine products offer the possibility of developing complex targeting approaches as well as multifunctionality. Nanotechnology has been examined for the detection of extracellular cancer biomarkers and cancer cells, as well as in vivo imaging, sensitive and selective, accuracy, and multiplexed detection capacity. In fact, nanoparticles have the potential to not only address the limitations of traditional cancer diagnosis and treatment, but also to open up entirely new possibilities and develop cutting-edge technology for tumour detection and treatment. Nano carriers are used to increase target tumour cell specificity and delivery capability to the tumour site, enhancing therapy efficacy while reducing unwanted side effects. Nanocarriers that respond to exogenous or endogenous stimuli have emerged as a promising alternative to target drug delivery. In this review intervention of nanoparticle system for cancer types like Lung cancer, Breast cancer, Melanoma, Colorectal cancer, Bladder cancer are discussed. Further focused on the advancement of nanocarriers for cancer diagnosis and treatment. The critical review takes deeper insight on nanocarrier-based cancer therapy.